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Human iPSC-derived 
cardiomyocytes cultured in 3D 
engineered heart tissue show 
physiological upstroke velocity and 
sodium current density
Marc D. Lemoine1,2,3, Ingra Mannhardt2,3, Kaja Breckwoldt2,3, Maksymilian Prondzynski2,3, 
Frederik Flenner2,3, Bärbel Ulmer2,3, Marc N. Hirt2,3, Christiane Neuber2,3, András Horváth2,4, 
Benjamin Kloth5, Hermann Reichenspurner5, Stephan Willems1,3, Arne Hansen2,3, Thomas 
Eschenhagen2,3 & Torsten Christ2,3
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) are a promising tool for 
drug testing and modelling genetic disorders. Abnormally low upstroke velocity is a current limitation. 
Here we investigated the use of 3D engineered heart tissue (EHT) as a culture method with greater 
resemblance to human heart tissue in comparison to standard technique of 2D monolayer (ML) 
format. INa was measured in ML or EHT using the standard patch-clamp technique. INa density was 
~1.8 fold larger in EHT (−18.5 ± 1.9 pA/pF; n = 17) than in ML (−10.3 ± 1.2 pA/pF; n = 23; p < 0.001), 
approaching densities reported for human CM. Inactivation kinetics, voltage dependency of steady-
state inactivation and activation of INa did not differ between EHT and ML and were similar to previously 
reported values for human CM. Action potential recordings with sharp microelectrodes showed similar 
upstroke velocities in EHT (219 ± 15 V/s, n = 13) and human left ventricle tissue (LV, 253 ± 7 V/s, n = 25). 
EHT showed a greater resemblance to LV in CM morphology and subcellular NaV1.5 distribution. INa in 
hiPSC-CM showed similar biophysical properties as in human CM. The EHT format promotes INa density 
and action potential upstroke velocity of hiPSC-CM towards adult values, indicating its usefulness as a 
model for excitability of human cardiac tissue.
Animal-heart tissue is commonly used as a model for human-heart tissue, but exhibits a significantly different 
action potential (AP) duration and shape, due to different ion channel contributions, interactions and regulation. 
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) have the great advantage of generat-
ing human-like AP-duration and shape. In addition, hiPSC-CM represent a theoretically unlimited source of CM, 
lacking the ethical concerns that come along with sacrificing animals. The recent progress in the development 
and generation of hiPSC provides great opportunities to study individualised cardiac electrophysiology, focusing 
on genetic disorders1 and individualised drug treatment2. However, there are concerns about the immaturity of 
hiPSC-CM3. One important difference relates to AP upstroke-velocity which, in initial publications, was found 
to be markedly lower (~2–50%) in hiPSC-CM4–6 than in adult CM7. These findings suggest lower sodium current 
(INa) density in hiPSC-CM, which is of great physiological importance as INa determines excitability, conductance 
velocity, refractoriness and triggered activity. Furthermore, INa is an established drug target for antiarrhythmic 
therapy (flecainide, propafenone, amiodarone, vernakalant and ranolazine). Recent improvements have been 
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brought about by co-culture with non-cardiac cells8, long-term culture9, hormone stimulation1, continuous field 
stimulation10 and variation of substrate stiffness11, 12, revealing upstroke velocities of up to 147 V/s12. While these 
values approach the expected range (200–300 V/s) for human adult ventricular tissue, differences remain and a 
head-to-head comparison under same conditions is lacking.
An alternative approach to increase the maturation of hiPSC-CM is cardiac tissue engineering13. CM in 
hydrogel-based engineered heart tissue (EHT) form a synchronously beating syncytium, which generates con-
tractile force by rhythmically deflecting the two elastic silicone posts it is attached to and thereby performs auxo-
tonic contractile work14, 15. Morphological and functional evidence suggest that hiPSC-CM reach a higher degree 
of maturity in EHT15, but electrophysiological data are lacking. Here we directly compared upstroke velocity in 
hiPSC-CM cultured in 3D (EHT) and in human heart tissue biopsies obtained during the implantation of left 
ventricular assist devices (LVAD) or heart transplantation, and studied INa properties in hiPSC-CM from 2D 
monolayers (ML) and EHT under the conditions published for human adult CM.
Results
Cell capacitance and sodium current. We compared the INa of EHT with standard 2D ML using the 
whole-cell patch clamp technique. Cell size as measured by the cell capacitance showed no statistically significant 
difference between EHT and ML (Fig. 1A): EHT 28.2 ± 2.0 pF (n = 37) vs. ML 23.3 ± 1.9 pF (n = 38). We studied 
INa at a reduced extracellular Na concentration, in order to ensure good voltage control and comparability to 
Figure 1. Cell capacitance and sodium current. (A) Scatter plot of cell capacitance in hiPSC-CM (mean values 
in Table 1). (B) Family of original Na current traces elicited by the protocol shown in the inset. (C) Scatter plot 
of INa density in hiPSC-CM for voltage-clamp pulse to −30 mV from a holding potential of −110 mV (EHT vs 
ML: ***p < 0.001). (D): Correlation of INa amplitude and cell capacitance. Best fit values for slope: ML 9.7 ± 2.4 
pA/pF vs. EHT 16.9 ± 5.9 pA/pF. Deviation from zero slope was significant for ML (p < 0.001) and EHT 
(p < 0.05).
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previous studies on human adult CM7, 16, 17. As expected, current amplitude showed a proportional relation to 
cell size (Fig. 1D). Mean INa density was remarkably higher (~80%) in EHT (−18.5 ± 1.9 pA/pF; n = 17) than in 
ML (−10.3 ± 1.2 pA/pF; n = 23; p < 0.001; Fig. 1C). I–V curves (Fig. 2A) show that the INa was activated around 
−55 mV and peaked at −30 mV in EHT and ML. EHT hiPSC-CM showed higher INa density than ML over the 
entire activation range (p < 0.05, Fig. 2A). Thus, EHT showed increased INa density in comparison to ML. To test 
for a late sodium current, we measured currents at the end of our test-pulse. Currents amounted to −68.9 ± 13.9 
pA under control condition and to −70.1 ± 13.9 pA after the application of 30 µM tetrodotoxin (TTX; n = 10, ns, 
paired t-test). Therefore, we did not find evidence for a persistent/late INa.
Inactivation, activation and recovery from inactivation. The contribution of INa to the electrical 
activity of CM depends critically on the voltage and time-dependent activation and inactivation. Activation 
curves were calculated from individual I–V curves by normalising peak current amplitudes for their actual driv-
ing force and a Boltzmann function was fitted to the data set (Fig. 2C). Voltages for the half-maximum activation 
(V0.5act) of INa and curve steepness (kact) did not differ between EHT and ML (Table 1). In order to characterise the 
inactivation kinetics of INa, we fitted a single exponential function to current traces at different test pulse poten-
tials (Fig. 2B). Time constants were shorter at increasing voltages of the test pulse without differences between 
EHT and ML.
In general, resting membrane potential (RMP) in CM is less negative than V0.5inact17. Therefore, only a minority 
of cardiac Na channels can be activated. Even small changes in RMP have strong effects on Na channel availabil-
ity. We simulated different RMPs by applying variable conditioning pre-pulses from −120 mV to −30 mV for 
1000 ms to determine steady-state inactivation. The mean data revealed no differences between EHT and ML in 
Figure 2. Biophysical properties of sodium current. (A) Current–voltage relationship in human induced 
pluripotent stem cell-derived cardiomyocytes: engineered heart tissue vs. monolayer, *p < 0.05. (B) Inactivation 
kinetics of INa were fitted by a single exponential function and characterised by the time constant τ as a function 
of the depolarisation step. An exemplary original trace of INa in EHT hiPSC-CM is shown (inset) with a function 
fitted as a dotted line and corresponding parameters. (C) Steady-state inactivation and activation relations 
for INa. The dotted lines represent fitted data calculated by a Boltzmann function. Insets show curves at higher 
magnification to illustrate the overlap at ~62.5 mV and maximal window current of 1–2%. (D) Recovery from 
inactivation of INa using a double-pulse protocol varying intervals (2 to 500 ms). Dotted line represents curve 
fits by a two-phase exponential function.
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V0.5inact or kinact (Table 1). A Boltzmann curve (Fig. 2C) showed that activation and steady-state inactivation curves 
overlap between ~−77 mV and ~−45 mV (inset Fig. 2C). The maximal overlap was reached at −61.9 mV (ML) 
and −61.3 mV (EHT), where normalised INa availability and conductance were 1.4% (EHT) and 1.8% (ML) of the 
maximum. EHT and ML did not differ in window current amplitude or in voltage-dependency.
The refractoriness of heart muscle depends critically on the fast recovery of INa from inactivation. The pro-
portion of second INa to first INa was decreased by shorter interpulse duration as shown by the mean data and the 
two-phase exponential fit (Fig. 2D). Fitting a two-phase exponential function to the data set of each individual 
cell revealed no difference between EHT and ML (Table 1).
Tetrodotoxin sensitivity and expression of sodium channel isoforms. TTX is a Na chan-
nel blocker with high affinity for neural isoforms and low affinity for cardiac isoforms of the Na chan-
nel. We found a concentration-dependent inhibition of INa in hiPSC-CM by TTX (Fig. 3A) with a sigmoidal 
concentration-response relationship. A single-site binding model could be fitted to the data points (Fig. 3C). 
The IC50 was calculated at 1.3 µmol/L (95% CI 1.1 and 1.6 µmol/L) with a slope factor of 1.08. A two-site binding 
model did not show a better fit. Applying the extra sum-of-square-test a single-site binding model was identified 
as the preferred fit. Our results argue against a relevant contribution of a high affinity binding site. Accordingly, 
transcript levels of the low-TTX-sensitive cardiac isoform NaV1.5 (SCN5A) were predominant without differ-
ences between EHT, ML and non-failing human left ventricular tissue (Fig. 3B), and the TTX-resistant neuronal 
isoform NaV1.8 (SCN10A) had 8-fold (LV), 50-fold (EHT) and 350-fold (ML) lower mRNA concentrations than 
NaV1.5 (SCN5A). Transcript levels of the neuronal isoform NaV 1.8 (SCN10A) were significantly lower in EHT- 
and ML-hiPSC-CM than in LV. Transcript levels of the highly-TTX sensitive brain-type isoforms NaV1.1–1.3, 
1.6 (SCN1A, SCN2A, SCN3A, SCN6A) fell mainly below the cycle threshold cut-off level of 30. At the begin-
ning of the differentiation from stem cells to cardiomyocytes SCN2A was the dominant isoform (Supplementary 
Figure 2). Expression levels of all isoforms described a U-shaped curve in development between day 0 and 20 of 
differentiation. However, at the late phase SCN5A clearly became the dominant isoform.
Action potential measurements. EHT beat spontaneously (EHT: 0.83 ± 0.12 Hz, N = 5), whereas LV 
tissue was quiescent. We paced EHT slightly above its intrinsic rate at 1 Hz pacing in order to compare data to LV 
tissue (Fig. 4) and to the literature (Table 2). AP upstroke velocity in EHT did not differ significantly from that 
recorded in LV tissue (EHT: 219 ± 15 V/s, n = 13, N = 6 vs. LV: 253 ± 16 V/s, n = 25, N = 5; ns; Fig. 4A and B). 
Maximum diastolic potential (MDP), RMP immediately before the upstroke (= take-off potential) and AP 
amplitude (Fig. 4B) also did not differ significantly between EHT (MDP: −78.4 ± 2.9 mV, RMP: –73.5 ± 1.6 mV, 
102.7 ± 2.8 mV, n = 13, N = 6) and LV (MDP: −74.8 ± 1.1 mV, RMP: −74.8 ± 1.1 mV, APA: 104.8 ± 1.4 mV, 
n = 25, N = 5).
Cell structure and subcellular distribution of NaV1.5. HiPSC-CM in EHT were oriented in parallel 
and showed a rod-shape morphology with sarcomere alignment comparable to LV tissue (Fig. 5). In contrast, 
hiPSC-CM in ML format showed an increased circularity and the sarcomeres were oriented in different direc-
tions even within the cell. NaV1.5 was distributed in the Z-disks and in the intercalated disks of adult cardiac 
tissue (Fig. 5). The subcellular distribution of NaV1.5 in ML hiPSC-CM was markedly different. It shows per-
inuclear enhancement with less pronounced signalling at the cell periphery and without co-localisation with 
α-actinin or enrichment at cell-cell contacts similar to what has been found in previous publications18–20. In 
contrast, hiPSC-CM in EHT showed a more pronounced expression of NaV1.5 in the periphery of the CM. Few 
CM in EHT showed co-localisation of NaV1.5 to Z-disks (arrowheads in Fig. 5B) and enhanced expression of 
ML n EHT n p-value
Cell capacitance (pF) 23.3 ± 1.9 38 28.2 ± 2.0 37 0.081
INa density (pA/pF) at −30 mV test 
pulse −10.3 ± 1.2 23 −18.5 ± 1.9 17 <0.001
Inactivation τ (ms) at −30 mV test 
pulse 1.68 ± 0.1 5 1.73 ± 0.1 9 0.758
Activation 6 9
V0.5 (mV) −34.6 ± 2.1 −36.2 ± 0.7 0.353
kact 5.8 ± 0.2 6.2  ± 0.2 0.187
Steady-state inactivation 10 11
V0.5 (mV) −89.8 ± 1.6 −91.3 ± 1.3 0.493
kinact 6.1 ± 0.5 6.7 ± 0.2 0.252
Recovery of inactivation 8 8
Proportion fast (%) 54.7 ± 14.1 49.7 ± 6.3 0.376
τfast (=1/kfast) (ms) 5.4 ± 1.3 6.7 ± 1.3 0.488
τslow (=1/kslow) (ms) 93.4 ± 17.3 90.4 ± 9.0 0.857
Table 1. Biophysical parameters of ML and EHT cultured hiPSC-CM. HiPSC-CM: human induced pluripotent 
stem cell-derived cardiomyocytes; n: number of cardiomyocytes; INa density measured at −30 mV from −110 
mV holding potential; V0.5: voltage of half-maximal (in)activation; k: slope factor of voltage-dependence of (in)
activation; τfast /τslow: fast and slow time constants of recovery from inactivation. Values are mean ± SEM.
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NaV1.5 at cell-cell contacts orthogonal to the CM orientation (arrow in Fig. 5B), comparable to the intercalated 
disk of adult cardiac tissue. Proper impulse propagation does not only depend on the sodium channels, but 
also on polarized connexin-43 expression. We found pronounced connexin-43 staining at the cell membranes of 
hiPSC-CM in EHT, but no clear enhancement at end-to-end over lateral cell-cell contacts typical of adult human 
LV (Supplementary Figure 3).
Discussion
In the present study, we investigated whether culture of hiPSC-CM in the EHT format leads to a higher resem-
blance with adult human CM in terms of INa density, upstroke velocity, CM morphology and subcellular distri-
bution of NaV1.5.
INa densities are difficult to compare among different studies, as experimental conditions differ widely with 
respect to temperature and Na concentrations (as listed in Table 2). Here we used the same experimental con-
ditions used previously to measure INa in human adult ventricular CM17, allowing for reliable comparisons with 
hiPSC-CM. Due to the limited availability of human adult ventricular tissue, studies analysing its electrophysi-
ological properties are rare. To our knowledge, only one publication has studied INa in human adult ventricular 
CM16 reporting an INa density of −20.2 pA/pF. Human atrial CM INa density measured under the same conditions 
amounted to −17.8 pA/pF, others reported values between −4 and -30 pA/pF7, 17, 21, 22. Thus, the INa densities in 
EHT hiPSC-CM (-18.5 pA/pF) fit nicely with ventricular and atrial adult CM. The observation that INa density in 
EHT CM was nearly two fold higher than CM cultured in conventional ML (−10.7 pA/pF) provides evidence for 
Figure 3. Concentration dependent effect of tetrodotoxin (TTX) on INa and expression of sodium channel 
subunits. (A) Representative original Na current tracings under control conditions and after exposure to 1, 
3 and 30 µmol/L of TTX. (B) Transcript levels of various Na channel isoforms were quantified by qPCR in 
3 samples each of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) in monolayer 
(ML) and engineered heart tissue (EHT) format and non-failing human left ventricle (LV). SCN10A showed 
a different expression for ML (***p < 0.001 vs. LV) and EHT (*p < 0.05 vs. LV). Sequences of primers are 
provided in Supplementary Table 1. CT stands for cycle threshold of PCR amplification. (C) Concentration-
response curve for TTX on INa in hiPSC-CM. Data are expressed as a normalized block (n = 3–9; total 30). 
In time-matched controls INa remains stable over several minutes (Supplementary Figure 1). IC50 indicates 
inhibitory concentration 50% of maximal response.
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the hypothesis that EHT culture improves the maturity of CM. The isometric mode of contraction of hiPSC-CM 
cultured on rigid surfaces (ML) in comparison to the auxotonic mode of contraction with defined load (EHT) 
might cause the difference in INa density. This supports recent data from hiPSC-CM cultured on soft substrate11, 12, 
suggesting that auxotonic work is essential for the development of proper INa density. INa density in mammalian 
CM increases constantly during cardiac development from embryonic to neonatal stages until the adult state23–25, 
which occurs in parallel with increasing SCN5A expression during differentiation and culture of hiPSC-CM 
(Supplementary Figure 2 and Fig. 3B). Thus, the increase in INa density might be part of the maturation process.
In order to elucidate potential mechanisms causing the greater INa density in EHT vs. ML, we reanalysed our 
previously published transcriptome of hiPSC-CM15. We focused on the expression of genes thought to influence 
INa. On the one hand, we found lower mRNA levels in EHT for the transforming growth factor beta 1 (TGFB1l1) 
which is a multifunctional cytokine and may reduce NaV1.5 expression26. On the other hand, we found higher 
mRNA levels in EHT of proteins believed to enhance INa function: epidermal growth factor (EGF), promot-
ing ubiquitously growth, proliferation and differentiation27; anchoring adaptor ankyrin-G (ANK3)28, which is 
involved in ion channel trafficking to the cell membrane, and plakophilin-2 (PKP2), which is part of cytoskeleton 
and cell-cell contact29. Interestingly, missense mutations in plakophilin-2 are known to cause arrhythmogenic 
right ventricular cardiomyopathy and INa deficit30.
The contribution of the short lasting INa to the AP also depends on inactivation kinetics, which can be charac-
terised by fitting a single exponential non-linear curve to the negative downslope of the INa. Inactivation kinetics 
revealed similar time constants and voltage-dependency in ML and EHT (Fig. 2B) fitting nicely to data reported 
for human adult CM21. The voltage-dependency of activation and steady-state inactivation were indistinguishable 
between EHT and ML (Fig. 2C), implying that the higher INa density in EHT may be explained by a greater num-
ber of functional Na channels. As experimental conditions like time after rupture and temperature are known 
to shift V0.5act and V0.5inact to approximately the same extent, we calculated the actual difference (delta) between 
V0.5act and V0.5inact. We found values of 55.1 mV and 55.3 mV for EHT and ML, respectively (Table 2), which are 
comparable to published data16, 17, 21 for adult CM (54–58 mV). This finding is in contrast to previous meas-
urements in hiPSC-CM cultured in ML showing markedly smaller values5, 12, 22, including a recent study that 
describes the culturing of hiPSC-CM on a soft substrate12. It is unclear if these discrepancies relate to technical 
differences or to intrinsic properties of different cell lines. Overall, we conclude that EHT format does not affect 
the voltage-dependent steady-state inactivation and activation in hiPSC-CM and these parameters are similar in 
our hiPSC-CM to that in human adult CM.
The difference (delta) between V0.5act and V0.5inact mentioned above is not trivial: more overlap should gen-
erate more window current. Previously published studies on hiPSC-CM5, 12, 22 have shown reduced differences 
(delta) between V0.5act and V0.5inact and as a consequence a higher calculated window current (4–12%, Table 2). 
Larger window currents may partly explain persistent/late INa in CM and might have a critical influence on AP 
duration31. In our experiments with hiPSC-CM, we found only a small amount of window current as in adult CM 
and no persistent/late INa. At the maximum degree of overlap (inset Fig. 2C), INa in hiPSC-CM showed similar 
fractions of maximal availability and conductance (1.4% and 1.8% for EHT and ML, respectively) as human adult 
CM (~2% and ~1% for atrial17 and ventricular CM16, respectively). It should be noted that the amount of window 
current might be an additional marker in the maturation process, since window currents decrease during the 
development of chick embryonic CM32.
Figure 4. Action potential characterisation. (A) Example of action potentials (AP) and the AP upstroke velocity 
(inset) measured in human induced pluripotent stem cell-derived cardiomyocytes cultured in engineered 
heart tissue (EHT) or in human left ventricular tissue (LV) at 36.5 °C paced at 1 Hz. (B) Corresponding AP 
parameters. N: number of EHTs/LV tissues; n: number of impalements with the sharp microelectrode. RMP, 
resting membrane potential; APA, action potential amplitude; dV/dt, maximum upstroke velocity; APD90, AP 
duration at 90% repolarisation.
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Interestingly, not only does the RMP influence INa density, but also vice versa, INa may influence RMP. Window 
INa may contribute significantly to RMP33, especially when inward rectifier currents are small, as in human atrial 
trabeculae. Imanishi et al. have shown that high concentrations of TTX hyperpolarized the membrane potential 
of quiescent human atrial trabecular by about 7 mV33. Consequently, window INa may be of particular relevance 
in hiPSC-CM, as less negative RMP and small inwardly rectifying potassium currents are consistently reported 
for hiPSC-CM34.
Sodium currents are known to recover quickly from voltage-dependent inactivation. Recovery from inactiva-
tion critically determines refractoriness and influences the susceptibility to tachyarrhythmia. In human adult atrial 
and ventricular CM recovery from inactivation could be fitted by a two-time constant function when plotting peak 
currents against different recovery time intervals16, 17. Earlier studies on hiPSC-CM from ML reported similar 
characteristics of recovery from inactivation as here22. It should be noted that both this study and Ma et al.5 found a 
somewhat faster recovery from inactivation in hiPSC-CM than in human adult CM. Whether this small difference 
has physiological relevance needs to be elucidated by computer modelling and functional studies.
We used TTX-inhibition of INa to evaluate whether non-cardiac isoforms contribute significantly to INa in 













(on Matri-gel) ML hiPSC ML hiPSC ML hiPSC
Capacitance (pF) 24.1 27.9 194 126 73.1 72.1 66 89 17.0 42 15.8
Peak INa density 
(pA/pF) −10.3 −18.5 −20.2 −17.8 −14 −30 −50.2 −37 −30.0 −160 −105 ~−68 −118 −264.4 −216.7
V0.5 activation 
(mV) −34.6 −36.2 −42.8 −38.9 −38.8 −50.2 −38.6 ~−44 −42.4 −42 −34.1
kact 5.8 5.9 6.0 6.5 5.3 7.2 1.8 5.9
V0.5 inactivation 
(mV) −89.8 −91.3 −97.3 −95.8 −97.1 −97.2 −95.1 −72.2 −77 −88.0 −82.8 −61.4 −72.1
kinact 6.1 7 5.8 5.3 6.2 7.4 4.9 7.6 5.7
∆V0.5(Act-Inact) 
(mV) 55.2 55.1 54.5 56.9 58.3 47.0 56.5 ~44 19.0 38.0
Overlap-potential 
(mV)* −61.5 −61.4 −70.5 −70.2 −71.9 −66.5 ~−61 −46.0 −53.4
Overlap-
availability (%)# 0.9 1.4 1.0 0.8 1.7 2.0 ~4 11.7 3.6
Days after 
differentiation 28 28 4–7 5–7 28 18 16
INa ext (mmol/L) 5 5 5 5 5 5 5 10 120 150 20 10 135 130 50
INa int (mmol/L) 5 5 5 5 5 5 5 10 70 10 5 5 5 5 10
Holding potential 
(mV) −110 −110 −140 −140 −120 −110 −140 −140 −135 −120 −140 −120 −90 −90 −80
Temperature (°C) 
for INa
21 21 17 17 23 21 22 22 24 21 37 22 24 36 36
Pulse frequency 
(Hz) 0.5 0.5 0.1 0.1 0.1 0.5 0.1 0.5 0.2
IC50 TTX 
(µmol/L) 1.4 1.7 1.1 10.6 0.6
Temperature (°C) 
for AP 37 37 37 37 22 22 24 21 37 22 24 36 36
MDP (mV) −78.4 −74.8 −72.6 −77.5 74.0 −60.9 −72.4 −75.6
RMP (=take-off) 
(mV) −73.5 −74.8 −72.6 −70.5
dV/dtmax (V/s) 219 253 230 146.5 84 13.1 115.7 27.8
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Table 2. Comparison of INa properties in isolated human induced pluripotent stem cell-derived and adult 
cardiomyocytes. HiPSC-CM: human induced pluripotent stem cell-derived cardiomyocyte; ML: monolayer; 
EHT: engineered heart tissue; V0.5: voltage of half-maximal (in)activation; k: slope factor of voltage-dependence 
of (in)activation; *overlap-potential (Vm) was calculated: ((kact*V0.5Inact)−(−kInact*V0.5act))/(kInact+kact) (details in 
supplementary data); #availability at overlap (%) was calculated = 1/(1+EXP((−V0.5Inact+overlap-potential)/kInact))*100; 
INa ext: sodium concentration of the extracellular (bath) solution, INa int: sodium concentration of the 
intracellular (pipette) solution; MDP: maximum diastolic potential; RMP: resting membrane potential (=take-
off potential); dV/dtmax: maximum upstroke velocity; APA: action potential amplitude.
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low nanomolar concentrations of TTX fits perfectly to a single-site binding model with low sensitivity (IC50 
1.3 µmol/L). Therefore, we would not assume relevant contribution from highly sensitive isoforms of Na channels 
to peak currents. Published TTX-sensitivities in atrial and ventricular CM amount to 1.1 µmol/L17 and 1.7 µmol/
L16 showing that the TTX-sensitivity of INa in hiPSC-CM was similar to that in adult CM. Quantitative evaluation 
of the transcript levels of different Na channel isoforms confirmed that expression was dominated by the expres-
sion of the low-TTX sensitive isoform NaV 1.5 (SCN5A) compared to the highly-TTX sensitive neuronal isoforms 
NaV 1.1–1.3, 1.6 (SCN1–3A, SCN6A). The TTX-resistant neuronal isoform NaV1.8 (SCN10A) was expressed at 
intermediate levels and showed lower absolute transcription levels in hiPSC-CM than in LV.
To the best of our knowledge, we show here for the first time AP in hiPSC-CM with an upstroke velocity 
similar to human adult ventricular tissue (200–300 V/s). Previous studies in hiPSC-CM have reported heteroge-
neous and overall lower upstroke velocities (Table 2) at ~40 V/s for ventricular-like AP in isolated cells4–6, 22 or in 
embryoid bodies9. Recent approaches to culture hiPSC-CM on a soft substrate of extracellular matrix as single 
CM11 or ML12 revealed higher INa density11, 12 and higher upstroke velocity of 147 V/s12 in comparison to cultures 
on a stiff substrate (65 V/s). Collectively, the data indicate that culture conditions allowing auxotonic contractions 
of hiPSC-CM against a flexible resistance increases the resemblance in INa density known for adult CM. This will 
Figure 5. Immunofluorescence analysis. Subcellular localisation of α-actinin (green), NaV1.5 (red) and nuclei 
(blue) in a whole mount immunofluorescent confocal section of left ventricular tissue (LV, two examples, A) 
and human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) in engineered heart tissue 
(EHT, two examples, B) and monolayer (ML, C). In contrast to ML, EHT showed a parallel orientation of CM, 
a more rod-shaped morphology, sarcomere alignment and NaV1.5 enhancement at cell-cell contact (arrow). In 
some parts of the EHT, NaV1.5 was co-localised with α-actinin at Z-disks (see arrowheads in inset with 2.5 fold 
magnification), comparable to LV. Scale bar for all images is 10 µm. Black rectangles were placed aside confocal 
images in A for symmetrical appearance.
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be important for the further use of hiPSC-CM in drug testing and modelling of genetically determined cardiac 
diseases.
We also found that AP in hiPSC-CM in EHTs showed a steeper early repolarisation and were considerably 
shorter than APs derived from LV tissue. A possible explanation is that APs from human tissue were all recorded 
from the subendocardial myocardium, which is known to express much less transient outward potassium current 
(Ito) and therefore exhibits longer APs than subepicardial regions35. Future work is warranted to evaluate whether 
APs in EHT are in fact “subepicardial-like” or whether the observed difference indicate a specific hiPSC-CM 
phenotype or a peculiarity of the cell line under investigation.
Immunohistochemistry revealed a parallel orientation of CM with a more rod-shaped morphology and sar-
comere alignment of hiPSC-CM than in ML (Fig. 5). Interestingly, the subcellular distribution of NaV1.5 in EHT 
hiPSC-CM showed an enhancement of NaV1.5 at cell-cell contacts and, in some CM, pronounced signals, sim-
ilar to those in the intercalated disks of the LV. Since NaV1.5 relocates from lateral to intercalated disks during 
cardiac development36, the enhancement of NaV1.5 in the direction of sarcomere orientation might be another 
hint for structural maturation of hiPSC-CM by the EHT format. Additionally, some hiPSC-CM in EHT showed 
co-localisation of NaV1.5 with α-actinin at Z-disks, while hiPSC-CM in ML did not, as shown previously19.
Although the EHT format facilitated structural maturation, the cell size of hiPSC-CM was similar to those in 
ML format (~25 pF) and much smaller in comparison to adult LV CM (~100–200 pF)17, 37. As cell size increases 
during the embryonic development of cardiomyocytes23, the small cell size may indicate an early stage of develop-
ment. Smaller cells have a greater membrane area to volume ratio, but the physiological relevance of this remains 
unclear. From a technical point of view, smaller cells should conduct smaller absolute membrane currents making 
patch-clamp studies more technically demanding38.
A limitation of this study is that all LV tissue was obtained from patients with advanced heart failure due to 
dilated cardiomyopathy, since access to living non-failing heart tissue is virtually impossible. We therefore cannot 
fully exclude electrophysiological differences to healthy tissue. However, previous publications have shown no 
differences in sodium current properties from failing or non-failing hearts17 and upstroke velocity in our hands 
were similar to values reported for non-failing human heart39.
In conclusion, we have characterized INa in hiPSC-CM in 3D EHT and conventional 2D ML culture and 
compared AP characteristics in hiPSC-EHTs and human ventricular tissue. The main findings are 1) a higher INa 
density and a similar upstroke velocity in EHT as in human adult ventricular tissue, 2) similar voltage-dependent 
inactivation and activation of INa in EHT and ML, 3) no evidence for relevant non-cardiac isoforms contributing 
to INa in hiPSC-CM and 4) a higher resemblance of hiPSC-CM in EHT to LV concerning structure and subcellu-
lar NaV1.5 distribution than ML. Thus, our data suggest that EHT culture of hiPSC-CM may improve the validity 
of in-vitro experiments studying electrophysiological questions.
Methods
An expanded method section is available in the supplementary data. Human materials and experimen-
tal protocols. This investigation conforms to all principles outlined by the Declaration of Helsinki and the Medical 
Associaton of Hamburg. According to the guidelines of the ethical review committee of the Medical Association of 
Hamburg, Germany, there is no need for a specific approval in this case since patient data were used anonymized. 
All materials from patients were taken with informed consent of the donors. Left ventricular free wall samples were 
obtained from patients undergoing implantation of left ventricular assist device (LVAD) or heart transplantation.
Generation and culture of human induced pluripotent stem cell-derived cardiomyocytes in engineered heart tissue 
and monolayer format. As previously described15, single cell suspensions of hiPSC-CM were either subjected 
to EHT generation in a 24-well format (1x106 hiPSC-CM/EHT in a fibrin matrix (total volume 100 µl) consisting 
of 10 µl/100 µl Matrigel [BD Bioscience, 256235], 5 mg/ml bovine fibrinogen (200 mg/ml in NaCl 0.9% [Sigma, 
F4753] plus 0.5 µg/mg aprotinin [Sigma, A1153]), 2x DMEM, 10 µM Y-27632 and 3 U/ml thrombin [Biopur, 
BP11101104]) or cultured conventionally in ML gelatin-coated 24-well plates (4x105 hiPSC-CM per well, 2 cm2). 
Culture media and duration were kept identical. For patch clamp measurements, hiPSC-CM in EHT and ML 
were isolated with collagenase II (200 U/ml, Worthington, LS004176) after a 24–29 day culturing period, and 
re-plated on gelatin-coated coverslips for 24–48 h in order to maintain adherence under perfusion.
Patch-clamp experiments. INa recordings were performed as described previously7. In brief, borosilicate glass 
microelectrode pipettes (tip resistances 1.5–3.0 MOhm) were used to record INa in whole-cell configuration at 
room temperature (21 ± 1 °C) with an Axopatch-200B amplifier (Axon Instruments, Foster City, CA). Pipette and 
bath solution contained 5 mmol/L NaCl.
Action potential measurements. APs were recorded as described previously7 with standard sharp micro-
electrodes in intact EHTs (25–60 days old) or LV tissue superfused with Tyrode´s solution at 36.5 ± 0.5 °C 
field-stimulated at 1 Hz (n = number of total impalements, N = number of EHT/LV tissue).
Immunofluorescence. Immunofluorescence was performed as described previously15. Briefly, EHT or LV tissue 
were fixed in formaldehyde overnight at 4 °C, blocked for 6 h and incubated with primary antibodies (monoclo-
nal mouse anti-α-actinin; monoclonal rabbit anti-NaV1.5) and secondary antibodies and nuclear staining (Alexa 
Fluor® 488 goat-anti-rabbit; Alexa Fluor® 546 goat-anti-mouse; DRAQ5TM). 2D cultures were cultivated on 
96-well plates and were fixed for 20 minutes at 4 °C and stained accordingly with the exception of using Hoechst 
33342 for nuclei staining.
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Statistics. GraphPad Prism 5 (GraphPad Software, San Diego, CA, USA) was used for data analyses. Curves 
were fitted to data points from individual experiments and all data were compared using unpaired t-tests and for 
groups greater than 2 One-way ANOVA followed by Tukey corrections. Two-way ANOVA was used to assess 
repeated measurements of current-voltage relationship (Fig. 2A). All analyses were two-tailed and a p < 0.05 was 
considered to be statistically significant. Group data are presented as mean ± SEM.
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